Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaad.2020.12.076 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists.
Dermatol Ther (Heidelb)
January 2025
Department of Dermatology, Emory University School of Medicine, 1525 Clifton Road NE, Atlanta, GA, 30322, USA.
Introduction: Acne impairs quality of life, often leads to permanent scars, and causes psychological distress. This review aims to update dermatologists on the Federal Drug Administration (FDA)-approved and off-label use of combined oral contraceptives (COC), clascoterone, spironolactone, and emerging hormonal therapies for acne treatment.
Methods: We reviewed current literature on hormonal acne treatments and discussed common patient concerns, barriers to care, and individualized care needs.
Combination of Multi-Acid Superficial Peel and Hyaluronic Acid Boosting: A Novel Prejuvenation Strategy.
Skinmed
January 2025
Dermatologic Center, "Villa Bella-Antiaging Care Group," Bologna, Italy.
Normal human life expectancy has increased; hence, growing interest in the field of skin quality is observed. Peels are common medical devices that stimulate new skin growth and improve texture. Injectable hyaluronic acid (HA)-based products act by replacing fragmented collagen.
View Article and Find Full Text PDFThe 2024 APLAR Consensus on the Management of Lupus Nephritis.
Int J Rheum Dis
January 2025
The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
The APLAR has published a set of recommendations on the management of systemic lupus erythematosus (SLE) in 2021. The current consensus paper supplements and updates specifically the treatment of lupus nephritis (LN) according to two rounds of Delphi exercise from members of the APLAR SLE special interest group, invited nephrologists, histopathologists, and lupus nephritis patients. For initial treatment of LN, we recommend a combination of glucocorticoids (GCs) with cyclophosphamide (CYC), mycophenolate mofetil (MMF), or the calcineurin inhibitors (CNIs) as first-line options.
View Article and Find Full Text PDFFactors associated with access to health services among people with long COVID in the Brazilian Amazon.
Front Public Health
January 2025
Graduate Program in Nursing at the Federal University of Pará (PPGENF/UFPA), Universidade Federal do Pará, Belém, Pará, Brazil.
Background: Access to healthcare services for the population with long COVID is a challenge, as healthcare systems have been tasked with responding effectively to the extensive clinical heterogeneity of this disease.
Objective: To analyze the factors associated with access to health services among people with long COVID in the Brazilian Amazon.
Methods: This is a cross-sectional study using a quantitative method, conducted through an online survey between May 2023 and January 2024.
[Dermatological diagnostics in patients with "skin of color"- How confident are German dermatologists?].
Z Evid Fortbild Qual Gesundhwes
December 2024
Klinik für Dermatologie und Allergologie, Universitätsklinikum Marburg, Philipps-Universität Marburg, Marburg, Deutschland. Electronic address:
Introduction: Diagnosis in dermatology is primarily based on the assessment and description of the clinical appearance of the skin. The German medical literature focuses almost exclusively on white skin, so it is questionable whether this one-sided training is sufficient to do justice to all patients since the diversity of skin types increases.
Methods: Online survey among German dermatologists regarding training and experience in the diagnosis of dark skin, difficulties in recognizing dermatoses and the desire for training and further education in skin diseases of "skin of color".
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!